• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov25
Annavik Life Sciences Reports No Revenue in FY2025, Cash and Operating Funds Decline
21:33
Anavex Life Science released FY2025 Annual Earnings on November 25 During-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5437 (forecast USD -0.5766)
21:00
Anavex Life Science released FY2025 Q4 earnings during market hours on November 25 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1144 (forecast USD -0.15)
21:00
Nov19
Anavex Life Sciences Corp. is a biopharmaceutical company focused on developing innovative treatments for multiple diseases
13:33
Nov18
Anavex Life Science to Release FY2025 Q4 Earnings on November 25 During-Market EST, Forecast Revenue USD 0, EPS USD -0.15
00:06
Nov14
Anavex Life Sciences faces negative vote from EMA's CHMP and requests re-examination
13:02

Schedules & Filings

Schedules
Filings
Nov25
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -9.827 M, EPS -0.1144

Aug12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -13.24 M, EPS -0.1551

May13
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -11.2 M, EPS -0.1316

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
BBGI
16.690
+312.10%
+12.640
SRV.RT
0.0900
+111.76%
+0.048
BEAT
1.550
+92.43%
+0.745
ENVB
10.330
+74.49%
+4.410
BDRX
6.720
+65.11%
+2.650
ASPC
16.810
+60.40%
+6.330
IRBT
5.240
+48.44%
+1.710
CGTL
0.9727
+47.40%
+0.313
MIGI
6.700
+45.65%
+2.100
PLAB
37.350
+45.39%
+11.660
View More